Home
ACXP
ACXP News

Latest Acurx Pharmaceuticals Inc. (ACXP) News on July 27, 2024

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

PR Newswire

10 days ago

USPTO Grants Acurx Pharmaceuticals New Patent for Ibezapolstat to Treat CDI While Reducing Recurrence of Infection and Improving Health of the Gut Microbiome

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update

PR Newswire

11 days ago

Acurx Pharmaceuticals, Inc. to Discuss Second Quarter 2024 Financial Results on August 9, 2024 Conference Call and Provide Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

PR Newswire

12 days ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results for CDI at Scientific Conference

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT

GlobeNewswire

2 months ago

New to The Street Announces Episode 576, Four Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, Thursday, June 6, 2024, at 9:30 PM PT

GuruFocus.com

2 months ago

Acurx Pharmaceuticals Inc (ACXP) Q1 2024 Earnings Call Transcript Highlights: Key Financial and ...

Thomson Reuters StreetEvents

2 months ago

Q1 2024 Acurx Pharmaceuticals Inc Earnings Call

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

PR Newswire

2 months ago

Acurx Announces Successful FDA End-of-Phase 2 Meeting and Phase 3 Readiness for Ibezapolstat in the Treatment of C. difficile Infection

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

PR Newswire

2 months ago

Acurx Pharmaceuticals, Inc. Reports First Quarter 2024 Results and Provides Business Update

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

PR Newswire

3 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

PR Newswire

3 months ago

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

PR Newswire

3 months ago

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update

Newsfile

4 months ago

Acurx Pharmaceuticals, Inc. Announces Participation in the LD Micro Invitational XIV

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Acurx Pharmaceuticals Inc Earnings Call

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully

Simply Wall St.

4 months ago

We Think Acurx Pharmaceuticals (NASDAQ:ACXP) Needs To Drive Business Growth Carefully

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

PR Newswire

4 months ago

Acurx Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

PR Newswire

5 months ago

Acurx Pharmaceuticals, Inc. to Discuss Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024 Conference Call and Provide Business Update

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

PR Newswire

5 months ago

Acurx Announces FDA Has Granted an End of Phase 2 Meeting for Ibezapolstat for C. difficile Infection and the European Medicines Agency Granted SME Designation for Ibezapolstat EU Development

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

GlobeNewswire

5 months ago

New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised Series

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

GlobeNewswire

5 months ago

New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PT

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT

GlobeNewswire

6 months ago

New to The Street Announces its 553rd Episode TV Line Up, Featuring Five Corporate Guests, Airing on the FOX Business Network, Monday, February 5, 2024, 10:30 PM PT

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

GlobeNewswire

6 months ago

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

IPO-Edge.com

6 months ago

REPLAY- AI From Racetracks to Trading Floors: CEO of Zapata AI and Co-CEO of Andretti Acquisition Corp. in Fireside Chat

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PR Newswire

6 months ago

Acurx Announces Positive Extended Clinical Cure Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

GlobeNewswire

6 months ago

New to The Street Announces Episode 551, Five Corporate Interviews, Airing on the FOX Business Network, Monday, January 29, 2024, at 10:30 PM PT

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

GlobeNewswire

6 months ago

FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

PR Newswire

6 months ago

Acurx Pharmaceuticals to Present at the Microcap Conference, January 31, 2024 - February 1, 2024

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

GlobeNewswire

6 months ago

New to The Street Airs on the FOX Business Network, Episode 550, Featuring Six Corporate Interviews, Broadcast Monday, January 22, 2024, at 10:30 PM PT

Industrial Logistics Properties Trust's Dividend Analysis

GuruFocus.com

6 months ago

Industrial Logistics Properties Trust's Dividend Analysis

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Benzinga

6 months ago

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today?

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

PR Newswire

6 months ago

Acurx Announces Positive Comparative Microbiology and Microbiome Data for Ibezapolstat from Phase 2b Clinical Trial in CDI Patients

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation

Business Wire

6 months ago

Industrial Logistics Properties Trust Announces 2023 Dividend Allocation

Sidoti Events, LLC's Virtual January Micro-Cap Conference

ACCESSWIRE

6 months ago

Sidoti Events, LLC's Virtual January Micro-Cap Conference

The Economist

6 months ago

AI can transform education for the better

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

Business Wire

6 months ago

Industrial Logistics Properties Trust Announces Quarterly Dividend on Common Shares

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

GlobeNewswire

7 months ago

SYLA Technologies Appoints Takuya Hanada as Chief Financial Officer

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

ACCESSWIRE

7 months ago

TEAF Provides Unaudited Balance Sheet Information and Asset Coverage Ratio Updates as of December 29, 2023

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

GlobeNewswire

7 months ago

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024

InvestorPlace

7 months ago

Small-Cap Sensations: 3 Stocks Predicted for Massive Growth in 2024

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen

GlobeNewswire

7 months ago

SYLA’s Rimawari-kun Platform’s Gross Merchandise Value Surpasses Five Billion Yen

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

GlobeNewswire

7 months ago

Smart Share Global Limited Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Simply Wall St.

7 months ago

Taylor Devices (NASDAQ:TAYD) Shareholders Will Want The ROCE Trajectory To Continue

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024

GuruFocus.com

7 months ago

Mama`s Creations Inc (MAMA) Reports Strong Revenue and Net Income Growth in Q3 Fiscal 2024

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

PR Newswire

7 months ago

Lument Finance Trust, Inc. Declares Quarterly Cash Dividends for its Common and Preferred Stock

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire

7 months ago

Mama’s Creations Reports Third Quarter Fiscal 2024 Financial Results

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

PR Newswire

8 months ago

Nektar and Collaborators Present Preclinical Data on NKTR-255 Combined with Obinutuzumab in Poster Presentation at the 65th American Society of Hematology (ASH) Annual Meeting

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Zacks

8 months ago

Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report?

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Business Wire

8 months ago

Upland FileBound Named a Gold Medalist in the 2023 SoftwareReviews ECM Data Quadrant Report

Wind, Climate Change, And The Future

ACCESSWIRE

8 months ago

Wind, Climate Change, And The Future

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

ACCESSWIRE

8 months ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Business Wire

8 months ago

OFS Credit Company Declares Monthly All-Cash Common Stock Distributions for Each of the Three Months in the Quarter Ending January 31, 2024

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

Smart Share Global Limited (NASDAQ:EM) Q3 2023 Earnings Call Transcript

Business Wire

8 months ago

Broadway Financial Corporation Announces Notification From Nasdaq Regarding Delinquent Form 10-Q

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire

8 months ago

Tempest to Present at the 35th Annual Piper Sandler Healthcare Conference

OFS Credit Company Provides October 2023 Net Asset Value Update

Business Wire

8 months ago

OFS Credit Company Provides October 2023 Net Asset Value Update

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

Zacks

8 months ago

Has Aveanna Healthcare (AVAH) Outpaced Other Medical Stocks This Year?

Bakkt Reports Third Quarter 2023 Results

Business Wire

8 months ago

Bakkt Reports Third Quarter 2023 Results

Lument Finance Trust Reports Third Quarter Results

PR Newswire

8 months ago

Lument Finance Trust Reports Third Quarter Results

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

GlobeNewswire

9 months ago

Arbutus Biopharma and Barinthus Bio Present Preliminary Data from Phase 2a Clinical Trial Combining Imdusiran with VTP-300 at AASLD - The Liver Meeting®

Bakkt Announces Expansion of International Footprint and Custody Client Base

Business Wire

9 months ago

Bakkt Announces Expansion of International Footprint and Custody Client Base

GuruFocus.com

9 months ago

Xtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 Guidance

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

GlobeNewswire

9 months ago

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates

GuruFocus.com

9 months ago

Vaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business Updates

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

GlobeNewswire

9 months ago

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

Business Wire

9 months ago

Spruce Biosciences to Participate in the Jefferies London Healthcare Conference

Share on Social Networks: